Mannkind Corp (MNKD) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Mannkind reported revenue of $349.0M, up 22.2% from $285.5M the year before. Net income was $5.9M (a 1.7% net margin), or $0.02 per diluted share. Gross margin was 92.3% and operating margin was 11.1%. Operating activities generated $18.3M of cash, leaving $13.7M of free cash flow. At fiscal year end, Mannkind held $792.2M in total assets against $843.2M in total liabilities, including $74.9M of cash and equivalents.
Open the full interactive Mannkind financials → Quarterly statements, key ratios, valuation history and price charts.
Mannkind Key Stats
| Share Price | $3.05 |
|---|---|
| Market Cap | $943.0M |
| P/E Ratio | 152.5 |
| Revenue YoY Growth | +22.2% |
| 52-Week Range | $2.28 – $6.21 |
| Shares Outstanding | 309.2 million (basic, 2026 Q2) |
Mannkind Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $65.1M | $75.4M | $99.8M | $199.0M | $285.5M | $349.0M |
| Cost of Goods Sold | $15.1M | $16.8M | $16.0M | $20.9M | $17.4M | $26.8M |
| Gross Profit | $50.1M | $58.6M | $83.8M | $178.1M | $268.1M | $322.2M |
| Operating Income | -$47.9M | -$47.0M | -$64.1M | $8.7M | $72.6M | $38.8M |
| Pre-Tax Income | -$57.5M | -$80.9M | -$87.4M | -$10.4M | $30.5M | $1.4M |
| Income Tax | -$218,000 | $0 | $0 | $1.6M | $2.9M | -$4.5M |
| Net Income | -$57.2M | -$80.9M | -$87.4M | -$11.9M | $27.6M | $5.9M |
| Diluted EPS | -$0.26 | -$0.32 | -$0.34 | -$0.04 | $0.10 | $0.02 |
Mannkind Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $82.1M | $112.0M | $90.2M | $109.4M |
| Net Income | $8.0M | -$15.9M | -$16.6M | -$19.0M |
| Diluted EPS | $0.03 | -$0.05 | -$0.05 | -$0.06 |
Mannkind Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $67.0M | $124.2M | $69.8M | $238.5M | $46.3M | $74.9M |
| Current Assets | $79.5M | $219.7M | $234.9M | $373.4M | $268.3M | $291.6M |
| Total Assets | $108.6M | $321.2M | $295.3M | $475.2M | $393.8M | $792.2M |
| Current Liabilities | $73.7M | $48.3M | $67.3M | $104.1M | $81.8M | $171.0M |
| Total Long-Term Debt | $122.2M | $281.2M | $273.5M | $268.7M | $36.1M | $354.6M |
| Total Liabilities | $289.0M | $530.5M | $545.8M | $721.4M | $472.7M | $843.2M |
| Shareholders' Equity | -$180.4M | -$209.3M | -$250.5M | -$246.2M | -$78.8M | -$51.0M |
Mannkind Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$28.1M | -$61.7M | -$80.7M | $34.1M | $42.5M | $18.3M |
| Cash From Investing | $15.2M | -$151.5M | $4.9M | -$2.0M | -$96.6M | -$304.8M |
| Cash From Financing | $49.9M | $270.3M | $21.4M | $136.6M | -$137.3M | $315.1M |
| Free Cash Flow | -$28.9M | -$73.2M | -$88.3M | -$8.3M | $32.8M | $13.7M |
Figures from Mannkind's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Mannkind financials page for every line item.
Mannkind Company Profile
| Ticker | MNKD |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Danbury, Connecticut |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000899460 |
Frequently Asked Questions
What was Mannkind's revenue in fiscal 2025?
Mannkind (MNKD) reported revenue of $349.0M for fiscal 2025.
What is Mannkind's annual revenue history?
Mannkind's annual revenue by fiscal year: 2020: $65.1M; 2021: $75.4M; 2022: $99.8M; 2023: $199.0M; 2024: $285.5M; 2025: $349.0M.
What was Mannkind's net income in fiscal 2025?
Mannkind reported net income of $5.9M for fiscal 2025.
What was Mannkind's earnings per share (EPS) in fiscal 2025?
Mannkind's diluted EPS was $0.02 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Mannkind generate in fiscal 2025?
Mannkind generated $13.7M of free cash flow in fiscal 2025.
What was Mannkind's revenue last quarter?
In its most recent reported quarter (2026 Q2), Mannkind reported revenue of $109.4M.
How much debt does Mannkind have?
Mannkind reported $354.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Mannkind are outstanding?
Mannkind reported a weighted average of 309.2 million basic shares outstanding in 2026 Q2.
What is Mannkind's market cap?
Based on its latest closing price, Mannkind (MNKD) has a market capitalization of about $943.0M.
When does Mannkind's fiscal year end?
Mannkind's fiscal year end, as registered with the SEC, is December 31.
Where is Mannkind headquartered?
Mannkind lists its business address in Danbury, Connecticut in its SEC filings.